Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Prostatic Hyperplasia 2Urinary Bladder, Neurogenic 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Spinal Dysraphism 1Spinal Cord Compression 1Sarcoma 1Neoplasms, Unknown Primary 1Melanoma 1Hypospadias 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1Bladder Exstrophy 1Adenocarcinoma 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Transurethral Resection of Prostate × Genitourinary × Clear all
NCT06820502 2025-02-11

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

Allama Iqbal Medical College

Phase NA Active not recruiting
60 enrolled
Genitourinary

Urinary Bladder Neoplasms, Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡